ELPLAT for Rectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where ELPLAT was used for Rectal cancer.
Most Reported Side Effects for ELPLAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Interstitial lung disease | 12 | 21.1% | 2 | 6 |
| Neuropathy peripheral | 10 | 17.5% | 2 | 6 |
| Neutrophil count decreased | 8 | 14.0% | 2 | 3 |
| White blood cell count decreased | 7 | 12.3% | 3 | 3 |
| Hyperammonaemia | 6 | 10.5% | 1 | 2 |
| Diarrhoea | 5 | 8.8% | 3 | 1 |
| Nausea | 5 | 8.8% | 2 | 2 |
| Platelet count decreased | 5 | 8.8% | 1 | 1 |
| Splenomegaly | 5 | 8.8% | 0 | 3 |
| Stomatitis | 5 | 8.8% | 3 | 2 |
Other Indications for ELPLAT
Other Drugs Used for Rectal cancer
CAPECITABINE (2,976)
OXALIPLATIN (2,402)
FLUOROURACIL (1,610)
BEVACIZUMAB (1,546)
TIPIRACIL\TRIFLURIDINE (1,297)
IRINOTECAN (985)
LEUCOVORIN (660)
CETUXIMAB (542)
REGORAFENIB (505)
PANITUMUMAB (374)